Generic name: Strattera
Strattera is used in the treatment of attention deficit hyperactivity disorder (ADHD) in children. Strattera is a prescription medication. Do not take Strattera if you:
Take Strattera by mouth. Your dose of Strattera will depend on the condition you are being treated for.
Strattera is usually taken 3 to 4 times a day. It is usually taken with or without food. Swallow the capsules whole. You can take Strattera with or without food. Do not crush, chew or break Strattera.
Strattera may be taken in different strengths or in different doses. Your doctor may start you on a low dose and increase the dose slowly, usually once weekly.
The dosage of Strattera may be adjusted to suit your condition. The starting dose is usually 25 mg or 50 mg. Your doctor may also increase your dose by 50 mg, depending on your body weight.
If you miss a dose, take it as soon as you can. If it is almost time for your next dose, take it as soon as you can. If it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not take a double dose.
Strattera tablets should be stored at room temperature in a dry place. Store it away from children's reach. Keep the medicine away from children's reach.
Seek emergency medical attention or call the Poison Help line at 1-800-222-1222.
Avoid getting into the eyes, mouth, or throat. Avoid touching the mouth or throat as well as inhaling. Do not use the inhaler with a liquid medicine or after the expiry date printed on the pack. The medicine can be irritating. Contact your doctor if you have any further concerns.
Get emergency medical help if you have any of these signs of an allergic reaction to Strattera: hives, difficulty breathing, swelling in your face or throat.
This product is a Prescription Only Medicine (S4) and is sold by Healthylife Pharmacy, an independently owned and operated pharmacy business. This prescription product requires a valid Australian script.
This product is temporarily unavailable.
Healthylife provides general product information such as nutritional information, country of origin and product packaging for your convenience. This information is intended as a guide only, including because products change from time to time. Please read product labels before consuming. For therapeutic goods, always read the label and follow the directions for use on pack. If you require specific information to assist with your purchasing decision, we recommend that you contact the manufacturer via the contact details on the packaging or email us at [email protected]. Product ratings and reviews are taken from various sources including Bazaarvoice. Healthylife does not represent or warrant the accuracy of any statements, claims or opinions made in product ratings and reviews.
healthcareylife_p CAPSULEhealthcareylife is a prescription-only medicine used to treat adults with attention deficit hyperactivity disorder (ADHD). Healthcareylife is available in 14 capsules, which is the amount of medicine that is required to treat an approved prescription medication. Healthcareylife is not suitable for children under 18 years of age.
This medicine is still in its original form. Healthylife has not been verified or used for this medicine sale.
Healthylife is available only with a doctor's prescription and is not used to treat a health condition. If you have a medical condition or are taking any other medication, it is important to use the service as directed.
Healthylife comes in in 14 capsules. Follow all directions on the pack to make sure that all the capsules are full. If you are taking any other form of healthcare, it is important to empty them into the oral liquid before swallowing. Always take medicine exactly as directed. Healthylife 60mg is a prescription-only medicine used to treat adults with attention deficit hyperactivity disorder (ADHD).
This medicine is currently unavailable.
Healthylife 60mg is a single dose capsule that can take three to six hours to start working. However, it is not suitable for children under 18 years of age or those with liver or kidney problems.
Healthylife is stored in a cool, dry place at a temperature not exceeding 25°C. The oral liquid medicine must be kept out of the reach of children.
Healthylife capsules should be kept in the original packaging or thehateiba container. Do notkeep the original packaging or containerarnetricallyale.
Healthylife capsules should not be kept in a place that could be seenending the medicine.
Healthylife isxiety medication is available for children who are onattentively hyperactive and may take this form of medication. This medicine has not been evaluated by the Food and Drug Administration (FDA) for safety and efficacy. If you are taking this form of healthcareformulary, do not stop taking this medicine without checking with your doctor.
Strattera, a non-stimulant medication, is primarily used to treat ADHD and other neurological conditions. It contains the active ingredient atomoxetine, which belongs to the group known as selective norepinephrine reuptake inhibitors (SNRIs).
Strattera works by preventing the reuptake of norepinephrine in the brain. This reuptake protects against symptoms such as trouble sleeping, excessive hunger, irritability, and impulsivity. By doing so, Strattera helps to reduce the amount of norepinephrine available in the brain.
The global Strattera market is projected to experience significant growth in the coming years. As of 2023, the market size was valued at USD 109.6 million and is projected to reach USD 154.6 million by 2031, growing at a Compound Annual Growth Rate (CAGR) of 2.3% in the forecast period from 2024 to 2031[1].
North America dominates the market, driven by peak demand for Strattera and relatively low prices for generic versions. This dominance is driven by the high prevalence of ADHD among this region’s patients, which leads healthcare professionals to recommend Strattera for patients in the North American market. North America also has a well-developed market for Strattera due to its advanced healthcare infrastructure and extensive research and development (R& D) programme. Major players include Amgen, Teva, Milagros, Teva Pharmaceutical Industries Ltd, Inc, Glenmark Pharmaceuticals Ltd, Glenmark Pharmaceuticals Ltd, Glenmark Pharmaceuticals Holding
The Asia-Pacific region provides a robust market for Strattera, driven by high healthcare expenditure, advanced infrastructure research and development, and improving access to mental health care. This region is covered by a broad range of policies, which includes provincial healthcare systems and the National Health Service (NHS).
Europe also has a well-established market for Strattera, further increasing the demand for this medication. Strattera manufacturers offer several R& D programmes to explore the potential of using Strattera for Europe. These could include R& D for the European Medicines Evaluation and Safety [2], Generic [3], and Dosage [4].
Latin America also has a well-established market for Strattera, but it contains a large amount of variance in terms of brand name and generic formulations. Latin America is believed to be the fastest-growing region, driven by a large prevalence of ADHD and advanced healthcare infrastructure. Latin America’s awareness of mental health conditions and its role in healthcare infrastructure also contribute to the growth of the market. Latin America’s rising awareness of health issues and the presence of healthcare professionals in it also make it a strong market in Latin America, such as the United States. Latin America’s focus on research and development also drives the growth of the market, as Latin America’s prevalence of ADHD also drives its sales[1].
One of the main benefits of Strattera is its clinical efficacy, which helps to define the most suitable treatment for a specific patient. Clinical trials demonstrate Strattera’s efficacy in various indications, such as treatment of ADHD and symptoms of major depressive disorder. These trials have highlighted the benefits of Strattera for patients with ADHD, such as its ability to improve focus and impulse control, as well as reduce impulsivity and hyperactivity[5].
The market is segmented based on several factors, including demographic factors, healthcare infrastructure, demand from individual patients, cost per prescription, and supply and demand dynamics. The ascending market players include Teva Pharmaceuticals, Amgen, Glenmark Pharmaceuticals Ltd, Glenmark Pharmaceuticals Ltd, Glenmark Pharmaceuticals Holding, Amgen’s G& B Laboratories, Milagros Pharmaceuticals, Milagros Corporation, Novartis AG, Teva Pharmaceutical Industries Ltd., Glenmark Pharmaceuticals Ltd., and Teva Pharmaceutical Industries Ltd. [6].
According to a 2023 report by Bensaler AG, Strattera was the most-prescribed medication in the Strattera market, with a total of 28 clinical trials evaluating its efficacy and safety.
Atomoxetine
Generic Name: Strattera
Brand Name: Atomoxetine
Category: Pills, Capsules, Capsule
Dosage form: Capsule, Tablet
Mechanism of action:
Strattera acts as a selective norepinephrine reuptake inhibitor, thus increasing norepinephrine levels in the brain and improving attention and impulse control.
The drug is well tolerated and can be used off-label for ADHD treatment, but it can also be used by children and adolescents under the age of 18 to treat other conditions.
Strattera is used to treat attention deficit hyperactivity disorder (ADHD). It is not recommended for use in children younger than 18 years old.
Atomoxetine is not a narcotic. It should not be used during pregnancy or while breastfeeding.
The drug should not be used for weight loss or as a sedative, as it may cause drowsiness or sedation. It can be used to treat high blood pressure, but it should not be used as an anti-nausea medication.
Strattera should not be taken by people who are allergic to it or those who are pregnant or nursing. It can also be used during breastfeeding or in people who cannot take other drugs with atomoxetine (such as sleeping pills, stimulants, benzodiazepines, and anticonvulsants).
Strattera can have adverse effects on your ability to drive or operate machinery, including drowsiness, blurred vision, headache, nausea, and dizziness.
Strattera can also cause drowsiness. This is due to its sedative effects. It is not recommended for use by children younger than 18 years of age.
Strattera may be dangerous when used for anxiety. It can cause drowsiness, dizziness, or nausea. It should not be used in children younger than 18 years of age.
Atomoxetine may increase the risk of seizures.
Strattera can make you dizzy or drowsy, which is common in adults and children.
Strattera should be used only with a doctor's prescription, and do not drive or operate machinery if you do not understand how to use it.
Tell your doctor if you are taking any other drugs, including medicines, vitamins, or supplements.
Strattera should not be used with alcohol or alcohol abuse medications.
Strattera is not approved for use in children under the age of 18 years.
Strattera should not be used in pregnant or breastfeeding women.
Strattera may cause drowsiness in some people. It may impair judgment or memory.
Tell your doctor if you have any medical conditions, including:
• seizures
• depression or any mental health problems
• liver or kidney problems
• diabetes
• liver or kidney disease
• kidney failure
• thyroid problems
• seizures, including mania
• loss of consciousness
• seizures or confusion
• numbness or tingling in the arms, hands, feet, or legs
If you are pregnant, you should not breastfeed or use atomoxetine.
Strattera should not be used in people who are breast-feeding.
During treatment, you may need to take a certain amount of medications to treat ADHD. The amount of medication you take depends on the type and severity of your condition.
Atomoxetine should not be used for children younger than 18 years of age.
Atomoxetine may increase the risk of developing a seizure.
Atomoxetine should not be used in children younger than 18 years of age.
Strattera is not approved for use in children younger than 18 years old.
Strattera should not be used during pregnancy or while breastfeeding.
Sold and Supplied by Healthylife Pharmacy
This product is a Prescription Only Medicine (S4) and is sold by Healthylife Pharmacy, an independently owned and operated pharmacy business. This prescription product requires a valid Australian script.
Healthylife provides general product information such as nutritional information, country of origin and product packaging for your convenience. This information is intended as a guide only, including because products change from time to time. Please read product labels before consuming. For therapeutic goods, always read the label and follow the directions for use on pack. If you require specific information to assist with your purchasing decision, we recommend that you contact the manufacturer via the contact details on the packaging or email us at [email protected]. Product ratings and reviews are taken from various sources including Bazaarvoice. Healthylife does not represent or warrant the accuracy of any statements, claims or opinions made in product ratings and reviews.
Stade de France Pharmacy